Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52

Fritz H. Schröder; Monique J. Roobol

doi:10.1016/j.eururo.2012.07.032

Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52

Fritz H. Schröder^*
, Monique J. Roobol

^*Corresponding author for this work

Urology

Research output: Contribution to journal › Comment/Letter to the editor › Professional

Abstract

The authors are grateful for the comments by Braillon and Dubois on our recent publication addressing the effect of screening on the diagnosis of prostate cancer (PCa) metastases in a randomized setting. The comments touch on some aspects that require discussion and clarification and, ultimately, will help promote a better understanding of our data.
Our data are derived from a subgroup of European Randomized Study of Screening for Prostate Cancer (ERSPC) centers based on data availability, as explained in our methods section. In our initial protocol, however, [...]

Original language	English
Pages (from-to)	e90-e91
Journal	European Urology
Volume	62
Issue number	5
DOIs	https://doi.org/10.1016/j.eururo.2012.07.032
Publication status	Published - Nov 2012

Bibliographical note

... on behalf of aal co-authors

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.eururo.2012.07.032

Fingerprint

Dive into the research topics of 'Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52'. Together they form a unique fingerprint.

1 Article

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)
Schröder, F., Hugosson, J., Carlsson, S., Tammela, T., Maattanen, L., Auvinen, A., Kwiatkowski, M., Recker, F. & Roobol - Bouts, M., 2012, In: European Urology. 62, 5, p. 745-752 8 p.
Research output: Contribution to journal › Article › Academic › peer-review

224 Citations (Scopus)

Cite this

Schröder, F. H., & Roobol, M. J. (2012). Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52. European Urology, 62(5), e90-e91. https://doi.org/10.1016/j.eururo.2012.07.032

Schröder, Fritz H. ; Roobol, Monique J. / Reply to alain braillon and gérard dubois' letter to the editor : re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52. In: European Urology. 2012 ; Vol. 62, No. 5. pp. e90-e91.

@article{8308e7db9651438b9ebfd0c88b7aaee0,

title = "Reply to alain braillon and g{\'e}rard dubois' letter to the editor: re: Fritz H. Schr{\"o}der, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52",

abstract = "The authors are grateful for the comments by Braillon and Dubois on our recent publication addressing the effect of screening on the diagnosis of prostate cancer (PCa) metastases in a randomized setting. The comments touch on some aspects that require discussion and clarification and, ultimately, will help promote a better understanding of our data. Our data are derived from a subgroup of European Randomized Study of Screening for Prostate Cancer (ERSPC) centers based on data availability, as explained in our methods section. In our initial protocol, however, [...]",

author = "Schr{\"o}der, \{Fritz H.\} and Roobol, \{Monique J.\}",

note = "... on behalf of aal co-authors",

year = "2012",

month = nov,

doi = "10.1016/j.eururo.2012.07.032",

language = "English",

volume = "62",

pages = "e90--e91",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "5",

}

Schröder, FH & Roobol, MJ 2012, 'Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52', European Urology, vol. 62, no. 5, pp. e90-e91. https://doi.org/10.1016/j.eururo.2012.07.032

Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52. / Schröder, Fritz H.; Roobol, Monique J.
In: European Urology, Vol. 62, No. 5, 11.2012, p. e90-e91.

Research output: Contribution to journal › Comment/Letter to the editor › Professional

TY - JOUR

T1 - Reply to alain braillon and gérard dubois' letter to the editor

T2 - re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52

AU - Schröder, Fritz H.

AU - Roobol, Monique J.

N1 - ... on behalf of aal co-authors

PY - 2012/11

Y1 - 2012/11

N2 - The authors are grateful for the comments by Braillon and Dubois on our recent publication addressing the effect of screening on the diagnosis of prostate cancer (PCa) metastases in a randomized setting. The comments touch on some aspects that require discussion and clarification and, ultimately, will help promote a better understanding of our data. Our data are derived from a subgroup of European Randomized Study of Screening for Prostate Cancer (ERSPC) centers based on data availability, as explained in our methods section. In our initial protocol, however, [...]

AB - The authors are grateful for the comments by Braillon and Dubois on our recent publication addressing the effect of screening on the diagnosis of prostate cancer (PCa) metastases in a randomized setting. The comments touch on some aspects that require discussion and clarification and, ultimately, will help promote a better understanding of our data. Our data are derived from a subgroup of European Randomized Study of Screening for Prostate Cancer (ERSPC) centers based on data availability, as explained in our methods section. In our initial protocol, however, [...]

UR - https://www.scopus.com/pages/publications/84867048697

U2 - 10.1016/j.eururo.2012.07.032

DO - 10.1016/j.eururo.2012.07.032

M3 - Comment/Letter to the editor

AN - SCOPUS:84867048697

SN - 0302-2838

VL - 62

SP - e90-e91

JO - European Urology

JF - European Urology

IS - 5

ER -

Schröder FH, Roobol MJ. Reply to alain braillon and gérard dubois' letter to the editor: re: Fritz H. Schröder, Jonas Hugosson, Sigrid Carlsson, et al. Screening for prostate cancer decreases the risk of developing metastatic disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC). Eur Urol 2012;62:745-52. European Urology. 2012 Nov;62(5):e90-e91. doi: 10.1016/j.eururo.2012.07.032

Abstract

Bibliographical note

UN SDGs

Access to Document

Other files and links

Fingerprint

Research output

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Cite this